Amedisys, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
86.00
39.00
160.00
280.00
210.00
170.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
39.00
-63.00
-105.00
-131.00
26.00
-31.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
221.00
137.00
133.00
188.00
288.00
202.00
Cash Flow from Investing Activities
-6.00
35.00
-85.00
-281.00
-287.00
-352.00
Cash Flow from Financing Activities
-51.00
-88.00
-39.00
54.00
-14.00
227.00
Net Cash Inflow / Outflow
164.00
84.00
8.00
-37.00
-13.00
76.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Amedisys, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
86.216
-417.54
503.00
120.65%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
39.895
-14.429
53.00
376.49%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
221.665
-184.76
405.00
219.97%
Cash Flow from Investing Activities
-6.152
-627.202
621.00
99.02%
Cash Flow from Financing Activities
-51.134
671.133
-722.00
-107.62%
Net Cash Inflow / Outflow
164.379
-140.338
304.00
217.13%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0.491
0.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 61.58% vs 2.93% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
221.66
137.19
61.58%






